Overview Money In Money Out People Positions Interview Endorsements
About Improving vision and lives through transplantation of ocular tissue and cells, innovation, research, education, and collaboration to advance treatments and patient outcomes.
Donations are tax-deductible
Financial Snapshot FY ending 2024-12-31 Financial history 16 17 18 19 20 21 22 23 24
Revenue Expenses
Latest FY2024: $8.7M · Peak FY2023: $9.5M · Avg: $7.5M
Address 5605 Glenn Ridge DR NE STE 25
Atlanta, GA, 30342-136
Governance Voting board members 14
Independent members 13
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board Yes
Compensation practices Severance payments No
Equity-based comp No
Supplemental retirement plan No
Compensation committee Yes
Board approved comp Yes
Initial contract exception No
Financial detail (Schedule D) Permanent endowment % 100.0%
Endowment held by related org No
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.